Serum lipid levels are positively associated with non-erosive reflux disease, but not with functional heartburn

Neurogastroenterology and Motility

Volumn 22, Issue 9, 2010, Pages

  Matsuzaki, J ^a   Suzuki, H ^a   Iwasaki, E ^b   Yokoyama, H ^c   Sugino, Y ^a   Hibi, T ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAISEIKAI CENTRAL HOSPITAL   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

dyslipidemia; functional heartburn; metabolic syndrome; NERD

Indexed keywords

LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ESOPHAGOGRAPHY; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; METABOLIC PARAMETERS; NON EROSIVE REFLUX DISEASE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SYMPTOM; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CROSS-SECTIONAL STUDIES; ESOPHAGITIS; ESOPHAGOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; LIPIDS; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 77955436610     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2010.01518.x     Document Type: Article

References (31)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults in JAMA. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001 285 : 2486 2497.
2. Bosello O, Zamboni M. Visceral obesity and metabolic syndrome. Obes Rev 2000 1 : 47 56.
3. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006 101 : 1900 1920 quiz 1943.
4. Moayyedi P, Talley NJ. Gastro-oesophageal reflux disease. Lancet 2006 367 : 2086 2100.
5. Chung SJ, Kim D, Park MJ et al. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut 2008 57 : 1360 1365.
6. Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol 2009 44 : 518 534.
7. Fass R. Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics. J Clin Gastroenterol 2007 41 : 131 137.
8. Wiklund I. Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig Dis 2004 22 : 108 114.
9. Ronkainen J, Aro P, Storskrubb T et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol 2005 40 : 275 285.
10. Modlin IM, Hunt RH, Malfertheiner P et al. Non-erosive reflux disease - defining the entity and delineating the management. Digestion 2008 78 (Suppl. 1 1 5.
11. Galmiche JP, Clouse RE, Balint A et al. Functional esophageal disorders. Gastroenterology 2006 130 : 1459 1465.
12. Martinez SD, Malagon IB, Garewal HS, Cui H, Fass R. Non-erosive reflux disease (NERD) - acid reflux and symptom patterns. Aliment Pharmacol Ther 2003 17 : 537 545.
13. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005 143 : 199 211.
14. Oliveria SA, Christos PJ, Talley NJ, Dannenberg AJ. Heartburn risk factors, knowledge, and prevention strategies: a population-based survey of individuals with heartburn. Arch Intern Med 1999 159 : 1592 1598.
15. Murray L, Johnston B, Lane A et al. Relationship between body mass and gastro-oesophageal reflux symptoms: The Bristol Helicobacter Project. Int J Epidemiol 2003 32 : 645 650.
16. Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 2003 290 : 66 72.
17. Diaz-Rubio M, Moreno-Elola-Olaso C, Rey E, Locke GR III., Rodriguez-Artalejo F. Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population. Aliment Pharmacol Ther 2004 19 : 95 105.
18. Nandurkar S, Locke GR III., Fett S, Zinsmeister AR, Cameron AJ, Talley NJ. Relationship between body mass index, diet, exercise and gastro-oesophageal reflux symptoms in a community. Aliment Pharmacol Ther 2004 20 : 497 505.
19. Park JH, Park DI, Kim HJ et al. Metabolic syndrome is associated with erosive esophagitis. World J Gastroenterol 2008 14 : 5442 5447.
20. Moki F, Kusano M, Mizuide M et al. Association between reflux oesophagitis and features of the metabolic syndrome in Japan. Aliment Pharmacol Ther 2007 26 : 1069 1075.
21. Modlin IM, Hunt RH, Malfertheiner P et al. Diagnosis and management of non-erosive reflux disease - the Vevey NERD Consensus Group. Digestion 2009 80 : 74 88.
22. El-Serag HB. Epidemiology of non-erosive reflux disease. Digestion 2008 78 (Suppl. 1 6 10.
23. Levine MS, Rubesin SE, Laufer I. Barium esophagography: a study for all seasons. Clin Gastroenterol Hepatol 2008 6 : 11 25.
24. Koehler RE, Weyman PJ, Oakley HF. Single- and double-contrast techniques in esophagitis. AJR Am J Roentgenol 1980 135 : 15 9.
25. Creteur V, Thoeni RF, Federle MP et al. The role of single and double-contrast radiography in the diagnosis of reflux esophagitis. Radiology 1983 147 : 71 5.
26. Iwasaki E, Suzuki H, Sugino Y et al. Decreased levels of adiponectin in obese patients with gastroesophageal reflux evaluated by videoesophagography: possible relationship between gastroesophageal reflux and metabolic syndrome. J Gastroenterol Hepatol 2008 23 (Suppl. 2 S216 21.
27. Carlsson R, Dent J, Bolling-Sternevald E et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998 33 : 1023 1029.
28. Kusano M, Shimoyama Y, Sugimoto S et al. Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol 2004 39 : 888 891.
29. Mishima I, Adachi K, Arima N et al. Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand J Gastroenterol 2005 40 : 1005 1009.
30. Carlsson R, Dent J, Watts R et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol 1998 10 : 119 124.
31. Ford AC, Forman D, Reynolds PD, Cooper BT, Moayyedi P. Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett's esophagus. Am J Epidemiol 2005 162 : 454 460.